News

Outpatient Treatment of Osteomyelitis with Telavancin

July 14, 2017

SUGAR LAND, TX (July 14, 2017) – Gram-positive osteomyelitis was successfully treated with telavancin, as published in an article in The International Journal of Antimicrobial Agents.  Primary author was…

Read more

Healix® is Now a National Provider of Cuvitru® [Immune Globulin Subcutaneous (Human)] 20%

March 20, 2017

SUGAR LAND, TX (March 20, 2017) - Healix has been selected among an exclusive number of distributers to become a national provider of Cuvitru [Immune Globulin Subcutaneous (Human)] 20%. Immunologists who partner with Healix…

Read more

Dalbavancin: A Nationwide Outpatient Experience in Physician Office Infusion Centers

June 13, 2016

SUGAR LAND, TX (May 23, 2016) – Dalbavancin is a long-acting lipoglycopeptide, approved for the treatment of acute bacterial skin and skin structure infections caused by susceptible gram-positive bacteria. A retrospective study was…

Read more

Antimicrobial Regimen and Safety of Pediatric Outpatient Treatment in a POIC

January 25, 2016

SUGAR LAND, TX (January 25, 2016) – Pediatric outpatient antimicrobial therapy (OPAT) is increasing, however, data on management, safety, and clinical outcomes are limited. A two-year retrospective, observational study was conducted of 64 pediatric…

Read more

A 2-Year Analysis of 30-Day Hospital Readmissions and Cost Benefits of Septicemia OPAT in a POIC

October 10, 2015

SAN DIEGO, CA (October 10, 2015) –  Septicemia constitutes a major cause for 30-day hospital readmissions and is the most expensive condition treated in U.S. hospitals according to the Agency for Healthcare…

Read more

Low Hospital Admission Rates Following POIC-Based Outpatient Treatment with Intravenous Antibiotics

December 1, 2014

PHILADELPHIA, PA (October 10, 2014) – Outpatient antimicrobial therapy (OPAT) provided by a physician office infusion center revealed an overall low 30-day hospital admission rate of 6.8% compared to 26% previously reported. This collaborative, retrospective study…

Read more

Comparison of Outpatient Antimicrobial Therapy (OPAT) in a POIC vs. Traditional Home Health Care

October 29, 2014

PHILADELPHIA, PA (October 10, 2014) – Outpatient antimicrobial therapy (OPAT) in a physician office infusion center showed improved quality of care in contrast to a traditional home health care setting. A collaborative, retrospective study…

Read more

Clinical Success in Outpatient Treatment of Complicated Urinary Tract Infections with Ertapenem

November 14, 2013

SAN FRANCISCO, CA (October 4, 2013) – A retrospective database review was conducted of patients aged 18 and older receiving ertapenem therapy for UTI between July 1, 2010, and December 31, 2013.  Seventy-five patients with a UTI diagnosis…

Read more

Clinical & Economic Outcomes of Outpatient Parenteral Antimicrobial Therapy among Indigent Patients

November 7, 2013

SAN FRANCISCO, CA (October 4, 2013) – This study is a report of clinical and economic outcome data of a hospital-funded Indigent Healthcare Program conducted in 11 Infectious Disease (ID) Physician Office Infusion Centers (POICs)…

Read more

Outpatient Parenteral Antimicrobial Therapy for Treatment of Complicated Intra-Abdominal Infections

October 25, 2013

SAN FRANCISCO, CA (October 4, 2013) – A multi-center retrospective review of 120 patients receiving intravenous antibiotics (IVAB) for complicated intra-abdominal infections (IAI) in a physician office infusion center (POIC) was conducted to determine the…

Read more

Vancomycin (VAN) Experience in Physician Office Infusion Centers (POICs)

October 9, 2013

SAN FRANCISCO, CA (October 9, 2013) – A multi-center review of 100 patients receiving Vancomycin was conducted to determine the effectiveness of patient monitoring and the recognition of adverse events in an outpatient setting. …

Read more

Successful Treatment of Polymicrobial Calcaneal Osteomyelitis

July 15, 2013

SUGAR LAND, TX – Multidrug-resistant osteomyelitis was successfully treated with telavancin, rifampin, and meropenem, as published in an article in The Annals of Pharmacotherapy.  Primary author was Mary Beth Brinkman, a…

Read more

C. difficile-Associated Diarrhea Incidence & Outcomes in Physician Office Infusion Centers

February 26, 2013

SAN DIEGO, CA (October 19, 2012) – A retrospective review of 1,352 patients treated at nine Infectious Disease POICs with intravenous antibiotics (IVAB) from January 1 to June 30, 2011, was conducted to assess the reduced risk level…

Read more

Cost & Outcomes Comparison of Patients Whose Treatment Began in Infusion Center vs. After Discharge

January 27, 2013

SAN DIEGO, CA (October 19, 2012) – A retrospective, multicenter review was conducted of eligible patients treated in the POIC from January 1- June 30, 2011, including 30-day follow-up to compare outcomes and costs in a…

Read more

Outcomes Comparison of IV Antimicrobials in an Office Infusion Center vs. Home Care Services

December 25, 2012

SAN DIEGO, CA (October 19, 2012) – A retrospective review was conducted of randomly selected records for patients treated in four Infectious Disease POICs from January 2010-December 2011, to compare patient management and outcomes in…

Read more

Utilization of IV Antimicrobials Over a One-Year Period in Physician Office Infusion Centers

November 28, 2012

SAN DIEGO, CA (October 19, 2012) – A multi-center retrospective review of 11,616 patients receiving intravenous antimicrobials (IVAM) was conducted to determine utilization of IVAM in POICs and efficient device utilization.  In the 65 participating…

Read more

Successful, Cost-Saving Outpatient Parenteral Antimicrobial Therapy Following Hospital Discharge

November 1, 2012

SAN DIEGO, CA (October 19, 2012) – A retrospective pilot study was conducted of all patients, from January 2011 through April 2012, receiving OPAT under an indigent healthcare program (a hospital-funded program providing IV antibiotics through…

Read more

Low Rates of C. difficile Associated Diarrhea in Patients Receiving IVAB in the Outpatient Setting

April 23, 2012

BOSTON, MA (October 21, 2011) – Patients receiving intravenous antibiotics in seven Infectious Disease Physician Office Infusion Centers (POICs) experienced a low rate of Clostridium difficile associated diarrhea (2.5 per 10,000 patient days).  Of the 934…

Read more

Low Readmission and Recurrence Rates of Bacteremia, Endocarditis & Osteomyelitis in Infusion Centers

February 26, 2012

BOSTON, MA (October 21, 2011) – A multi-center retrospective review of 203 patients treated with long term intravenous antibiotic therapy in physician office infusion centers (POICs) is effective with clinical success rates of 93% in bacteremia, 88%…

Read more

Treatment with IV Antibiotics in an Outpatient POIC Shows Successful Outcomes and Cost Savings

January 29, 2012

BOSTON, MA (October 21, 2011) – A 3-year trend analysis was conducted of  patients initiated on intravenous antibiotics (IVAB) in an Infectious Disease Physician Office Infusion Center (POIC) during the years 2008 – 2010 for…

Read more

Telavancin Treatment in the Outpatient Setting is Effective

October 21, 2011

BOSTON, MA (October 21, 2011) – In a 16 month period, 47 patients were treated with telavancin in 15 physician office infusion centers (POICs) with indications for acute bacterial skin and skin structure infections (24), osteomyelitis (19), sepsis (3), and…

Read more

Healix Launches New App to Boost Client Efficiency

January 20, 2011

SUGAR LAND, TX  (January 1, 2011) - Healix announced the official launch of the iPhone® compatible Healix App, a tool for on-the-go physicians to track formulary options with payer reimbursement data, patient…

Read more